Skip to main content

and
  1. No Access

    Protocol

    Conjugation Site Analysis by MS/MS Protein Sequencing

    In-depth knowledge about the site of drug-linker conjugation is important for the understanding of the conjugation efficiency and the exact locations of payloads for antibody-drug conjugates (ADCs). Here we de...

    Linjie Han, Yanqun Zhao, Qunying Zhang in Antibody-Drug Conjugates (2020)

  2. No Access

    Protocol

    SpyTag–SpyCatcher Chemistry for Protein Bioconjugation In Vitro and Protein Topology Engineering In Vivo

    The emergence of “molecular superglue,” such as SpyTag–SpyCatcher chemistry, has tremendously expanded our capability in manipulating protein shape and architecture via conjugation. Telechelic proteins bearing...

    **ao-Wei Wang, Wen-Bin Zhang in Bioconjugation (2019)

  3. No Access

    Protocol

    Site-Selective Enzymatic Labeling of Designed Ankyrin Repeat Proteins Using Protein Farnesyltransferase

    Affinity agents coupled to a functional moiety play an ever-increasing role in modern medicine, ranging from radiolabeled selective binders in diagnosis to antibody–drug conjugates in targeted therapies. In bi...

    Yi Zhang, Shelby Auger, Jonas V. Schaefer, Andreas Plückthun in Bioconjugation (2019)